Home
|
Job-opportunities
|
Contact
|
News
|
Donate
Overview
DNDi Worldwide
Business Model
Stakeholders
Friends of DNDi
Our People
Annual Report
DNDi's Policies
Endorsements
Letter from Chairman and Executive Director
Diseases
Portfolio
R&D Organisation
Building Portfolio
Clinical Trial Protocols
Open Innovation
ASAQ
ASMQ
NECT
SSG&PM
Paediatric Benznidazole
LEAP Platform
HAT Platform
Chagas Platform
Technology transfer ASMQ
Technology transfer ASAQ
Global
Access
IP
Regulatory
Sustainable Funding
Press Kit
Press Releases
Press Articles
Scientific Publications
Newsletters
Outlooks
Multimedia
Events
Press Room
Business Model
Partners
IP & Licensing Policies
To Become a DNDi Partner
How to help
Donors
Key Financial Figures
Fundraising Policy
Donate
Home
DNDi News
DNDi News
DNDi News
DNDi News
Click here
To subscribe to DND
i
monthly e-News !
DND
i
press releases
January 30, 2012
Filling R&D Gaps Key to Succeeding in NTD Control and Elimination Goals by 2020
January 30, 2012
DNDi and Abbott Expand Partnership
to Boost Innovation for Neglected Tropical Diseases
January 30, 2012
Private and Public Partners Unite to Combat 10 Neglected Tropical Diseases by 2020
January 23, 2012
Germany’s Federal Ministry of Education and Research Grants EUR 8 Million to DNDi for the Development of New Treatments for Neglected Tropical Diseases
December 2, 2011
New child-adapted Chagas disease treatment approved for registration
December 1, 2011
Children with HIV/AIDS Falling Through the Cracks of Treatment Scale-Up Efforts
November 7, 2011
Major Project with OWH and TDR to Support India and Bangladesh’s National Control Programmes in Implementing New Treatments to Boost Kala-Azar Elimination Strategies
October 26, 2011
DND
i
Joins WIPO Open Innovation Platform But Calls for More Ambitious Provisions for Innovation and Acces
s
DND
i
Scientific publications
DND
i
model: status and challenges
"Drugs for Neglected Diseases
initiative
model of drug development for neglected diseases: current status and future challenges" by Shing Chang and Jean-Robert Ioset
Future Medicinal Chemistry.
2011 September
Paediatric HIV: A neglected disease?
"Pediatric HIV - A Neglected Disease?" by Lallemant M et al.
The New England Journal of Medicine.
2011 August
Novel drug candidate for HAT
"SCYX-7158, an Orally-Active Benzoxaborole for the Treatment of Stage 2 Human African Trypanosomiasis" by Jacobs R.T et al.
PLoS NTD
. 2011 June
R&D for helminth infections
"Potential Drug Development Candidates for Human Soil-Transmitted Helminthiases" by Olliaro P et al.
PLoS NTD
. 2011 June
DND
i
in the media
December 17
, 2011
The Lancet: "Paediatric benznidazole"
December 8
, 2011
IPS: "Child-Adapted Formula to Deal Major Blow to Chagas Disease"
December 5
, 2011
El Universal: "Chagas infantil tiene su fármaco"-"Chagas paediatric gets its drug"
December
3, 2011
La Nacion: "Aprueban el primer medicamento pediátrico para Chagas"-"First paediatric treatment for Chagas approved"
December
3, 2011
The Lancet: "The Commission on Macroeconomics and Health: 10 years on"
November 11, 2011
MSF access campaign: "The search for the best treatment for Kala Azar in India"
November 10, 2011
The Times of India: "Study boost for elimination of kala-azar in India"
November 7, 2011
New York Times: "Kala Azar: Four-Year Test Seeks Better Ways to Treat a Persistent Disease Spread by Sand Flies"
November 7, 2011
Voice of America: "Billion People Suffer from Neglected Tropical Diseases"
November 7, 2011
El Mundo:"An international project to eliminate leishmaniasis" - "Un proyecto internacional para erradicar la leishmaniasis"
October 31, 2011
SciDev.net: "Major patent pool opens up research on neglected disease"
October 29, 2011
La Vanguardia: "Millions of people worldwide continue to be neglected" - "Millones de personas en el mundo siguen olvidadas"
October 27, 2011
IP Watch: "WIPO Re:Search Bridges Public, Private Sectors For Neglected Disease Research
"
SITEMAP
DISCLAIMER
PRIVACY
Except where otherwise noted, content on this site is licensed under
a Creative Commons Attribution-Noncommercial-Share Alike 2.5 Switzerland License